Back to Wells Fargo & Company Wells Fargo & Company

AXSMAXSM

Showing 8 of 28 quarters

Position history for Wells Fargo & CompanyWells Fargo & Company's holdings in Axsome Therapeutics, Inc.

Yes. Wells Fargo holds 53,915 shares of AXSM (Axsome Therapeutics), worth $13.2M, as of its Q2 2026 13F filing. It reduced the position by 7,490 shares (-12.2%) from Q1 2026. Wells Fargo has held AXSM in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$13.2M

Current Shares

53,915

Total Value Change

+$9.6M

Total Shares Change

+13,958

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
53,915
-12.2%
$13.2M0.0%$244.77
0
2026-Q1
Decreased
61,405
-31.5%
$10.4M0.0%$169.02
0
2025-Q4
Increased
89,661
+62.2%
$16.4M0.0%$182.64
41
2025-Q3
Decreased
55,273
-0.8%
$6.7M0.0%$121.45
0
2025-Q2
Increased
55,703
+33.9%
$5.8M0.0%$104.39
35
2025-Q1
Increased
41,615
+4.7%
$4.9M0.0%$116.63
28
2024-Q4
Decreased
39,736
-0.6%
$3.4M0.0%$84.61
0
2024-Q3
Decreased
39,957
-70.6%
$3.6M0.0%$89.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used